SBH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sally Beauty Holdings Inc (SBH) is not a strong buy at this moment for a beginner investor with a long-term focus. The technical indicators are neutral, options data shows a lack of bullish sentiment, and financial performance has shown a decline in key metrics like net income and EPS. While analysts have raised price targets and there are some positive catalysts, the overall sentiment and data do not strongly support an immediate buy decision.
The MACD histogram is negative at -0.0568, indicating bearish momentum, though it is contracting. RSI is at 34.285, which is neutral and does not indicate oversold or overbought conditions. Moving averages are converging, showing no clear trend. Key support is at 13.5, and resistance is at 14.635. The stock has a 60% chance of declining slightly in the next day and week, with a potential recovery in the next month.
Raymond James upgraded the stock to Outperform, citing store improvements and growth-driving initiatives. Gross margin has increased slightly YoY, showing operational efficiency.
Net income and EPS have declined significantly YoY (-25.33% and -22.41%, respectively). Revenue growth is minimal at 0.56% YoY. Hedge funds and insiders are neutral, with no significant trading activity. No recent news or congress trading data to drive momentum.
In Q1 2026, revenue increased slightly by 0.56% YoY to $943.17M. However, net income dropped by 25.33% YoY to $45.56M, and EPS declined by 22.41% YoY to 0.45. Gross margin improved marginally to 51.24%, up 0.79% YoY, indicating slight operational efficiency gains but not enough to offset declining profitability.
Analysts are mixed but leaning positive. TD Cowen and Canaccord have Buy ratings with price targets of $20, citing durable margins and growth-driving initiatives. Raymond James upgraded the stock to Outperform with a $19 target, highlighting store improvements. However, Morgan Stanley remains cautious with an Underweight rating and a $16 target, citing limited medium-term EBIT growth.
